Bioethics questions emerge from experimental drug used in COVID-19 treatment
The treatment that President Donald Trump has received to fight COVID-19 has turned the focus on an experimental drug that shows promise in combating the coronavirus but is raising ethical questions about the cell line that helped researchers develop the medicine.
Read More
Recent Comments